PDF Publication Title:
Text from PDF Page: 017
Avci et al. Page 17 91. Mandel AS, Haberman HF, Pawlowski D, Goldstein E. Non PUVA nonsurgical therapies for vitiligo. Clin Dermatol. Nov-Dec;1997 15(6):907–919. [PubMed: 9404694] 92. Khullar SM, Brodin P, Barkvoll P, Haanaes HR. Preliminary study of low-level laser for treatment of long-standing sensory aberrations in the inferior alveolar nerve. J Oral Maxillofac Surg. Jan; 1996 54(1):2–7. discussion 7–8. [PubMed: 8530994] 93. Anders JJ, Borke RC, Woolery SK, Van de Merwe WP. Low power laser irradiation alters the rate of regeneration of the rat facial nerve. Lasers Surg Med. 1993; 13(1):72–82. [PubMed: 8426530] 94. Rochkind S, Rousso M, Nissan M, Villarreal M, Barr-Nea L, Rees DG. Systemic effects of low- power laser irradiation on the peripheral and central nervous system, cutaneous wounds, and burns. Lasers Surg Med. 1989; 9(2):174–182. [PubMed: 2716462] 95. Mandel A. Skin repigmentation after laser therapy. Vestn Dermatol Venerol. Sep.1984 (9):26–29. [PubMed: 6524045] 96. Yu HS. Treatment of vitiligo vulgaris with helium-neon laser. MB Derma. 2000; 35(13–18) 97. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA. Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A. Jul; 1988 85(14):5282– 5286. [PubMed: 2839841] 98. Wu CS, Lan CC, Chiou MH, Yu HS. Basic fibroblast growth factor promotes melanocyte migration via increased expression of p125(FAK) on melanocytes. Acta Derm Venereol. 2006; 86(6):498–502. [PubMed: 17106595] 99. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol. Oct; 1993 101(4):605–608. [PubMed: 8409531] 100. Hedley SJ, Wagner M, Bielby S, Smith-Thomas L, Gawkrodger DJ, MacNeil S. The influence of extracellular matrix proteins on cutaneous and uveal melanocytes. Pigment Cell Res. Feb-Apr; 1997 10(1–2):54–59. [PubMed: 9170163] 101. Ma HJ, Zhu WY, Wang DG, Yue XZ, Li CR. Endothelin-1 combined with extracellular matrix proteins promotes the adhesion and chemotaxis of amelanotic melanocytes from human hair follicles in vitro. Cell Biol Int. Dec; 2006 30(12):999–1006. [PubMed: 16990029] 102. Ideta R, Soma T, Tsunenaga M, Ifuku O. Cultured human dermal papilla cells secrete a chemotactic factor for melanocytes. J Dermatol Sci. Jan; 2002 28(1):48–59. [PubMed: 11916130] 103. Takano N, Kawakami T, Kawa Y, et al. Fibronectin combined with stem cell factor plays an important role in melanocyte proliferation, differentiation and migration in cultured mouse neural crest cells. Pigment Cell Res. Jun; 2002 15(3):192–200. [PubMed: 12028583] 104. Gibson WT, Couchman JR, Weaver AC. Fibronectin distribution during the development of fetal rat skin. J Invest Dermatol. Dec; 1983 81(6):480–485. [PubMed: 6358375] 105. Uitto J, Kouba D. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci. Dec; 2000 24 (Suppl 1):S60–69. [PubMed: 11137398] 106. Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. Feb; 2009 35(2): 171–181. [PubMed: 19215252] 107. Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol. Jan; 2007 46(1):80–88. [PubMed: 17214728] 108. Louw L. The keloid phenomenon: progress toward a solution. Clin Anat. Jan; 2007 20(1):3–14. [PubMed: 16944532] 109. Uitto J. IL-6 signaling pathway in keloids: a target for pharmacologic intervention? J Invest Dermatol. Jan; 2007 127(1):6–8. [PubMed: 17170717] 110. Ghazizadeh M, Tosa M, Shimizu H, Hyakusoku H, Kawanami O. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. Jan; 2007 127(1):98–105. [PubMed: 17024100] 111. Liu W, Wang DR, Cao YL. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther. Mar; 2004 4(1):123–136. [PubMed: 15032619] 112. Barolet D, Boucher A. Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: a case series. Lasers Surg Med. Aug; 2010 42(6):597–601. [PubMed: 20662038] Semin Cutan Med Surg. Author manuscript; available in PMC 2014 August 08. NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptPDF Image | Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring
PDF Search Title:
Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoringOriginal File Name Searched:
nihms430657.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com (Standard Web Page)